Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4649577 | 0.85 | USP2 (0.46) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL14391447 | 0.84 | USP2 (0.34) | USP2LMNATHRB | |
| SCHEMBL14419224 | 0.84 | USP2 (0.34) | USP2LMNATHRB | |
| SCHEMBL5342645 | 0.82 | USP2 (0.43) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL13573098 | 0.82 | LMNA (0.38) | LMNAKDM4ETHRBMGAM | |
| SCHEMBL9443589 | 0.82 | LMNA (0.38) | LMNAKDM4ETHRBMGAM | |
| SCHEMBL12846443 | 0.81 | TSHR (0.45) | USP2ALDH1A1CNR1CNR2HTT | |
| SCHEMBL14628004 | 0.80 | ALDH1A1 (0.37) | ALDH1A1LMNATHRB | |
| SCHEMBL20788856 | 0.79 | USP2 (0.50) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL20788813 | 0.79 | USP2 (0.50) | USP2ALDH1A1CNR1CNR2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140301998-A1 | PREPARATION CONTAINING DIOL | BEIERSDORF AG (DE) | 2014-10-09 | — | — | US | disclosed |
| EP-1902043-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | Takasago International Corporation (JP) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007004740-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301998-A1 | PREPARATION CONTAINING DIOL | DHCR7, ADH1C, DHCR24 | USP2 848/4885ALDH1A1 93/4885CNR1 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.